In asthma, TSLP is increased in the airways of humans and rodents [12], and an anti-TSLP monoclonal antibody, tezepelumab, was effective and safe for the treatment of severe asthma in a phase 3 clinical trial [13]. This evidence concerns the gene TSLP and asthma.